Cerivastatin approval expands HMG-CoA reductase inhibitor choices

Am J Health Syst Pharm. 1997 Aug 15;54(16):1793. doi: 10.1093/ajhp/54.16.1793.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval
  • Enzyme Inhibitors* / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Hypercholesterolemia / drug therapy
  • Pyridines* / therapeutic use
  • United States
  • United States Food and Drug Administration

Substances

  • Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyridines
  • cerivastatin